Milestone Pharmaceuticals Inc. - Common Shares — 분기별 현금 흐름 (NASDAQ:MIST) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 75.5 M61.88 M47.42 M87.75 M113.56 M193.73 M 총 부채 62.35 M68.01 M65.16 M67.25 M71.79 M157.69 M 자본금 총액 13.15 M-6.12 M-17.75 M20.5 M41.77 M36.05 M 총 부채 및 주주자본 75.5 M61.88 M47.42 M87.75 M113.56 M193.73 M 총부채 —————— 순부채 ——————

뉴스

Milestone Pharmaceuticals Inc. (MIST) Q1 2026 Earnings Call Transcript

Milestone Reports Q1 Results, Highlights Initial CARDAMYST Sales - Milestone Pharmaceuticals (NASDAQ:MIST

Milestone Pharmaceuticals (MIST) Reports Q1 Loss, Lags Revenue Estimates

Milestone Pharmaceuticals Inc. (MIST) Q4 2025 Earnings Call Transcript

Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Milestone Pharmaceuticals (NASDAQ:MIST)

Milestone Stock: Downgrading To Sell As CARDAMYST Faces A Tough Reality (NASDAQ:MIST)

Milestone Pharmaceuticals appoints David Sandoval as general counsel

All You Need to Know About Milestone Pharmaceuticals (MIST) Rating Upgrade to Strong Buy

Milestone’s PSVT treatment CARDAMYST now available in US pharmacies

Milestone Pharmaceuticals: Selling The News On Cardamyst Approval Makes No Sense (MIST)

Aptar, 새로운 PSVT 치료제 전달 나잘 스프레이 시스템

Milestone Pharmaceuticals: Cardamyst Beat Placebo, But The Commercial Bar Is Higher (MIST)